DNA methylation profiles can be used to stratify psoriasis patients by clinical features, including age of disease onset and IL-22 copy number variation, allowing the potential future use of epigenomics in classifying psoriasis patients for diagnostic or treatment purposes [199]. The gene discussed is IL22; the disease is psoriasis.